Sales rise 98.21% to Rs 1.11 crore Net Loss of Zenotech Laboratories reported to Rs 4.31 crore in the quarter ended September 2014 as against net loss of Rs 7.40 crore during the previous quarter ended September 2013. Sales rose 98.21% to Rs 1.11 crore in the ... Business Standard, 2 months ago
will hold a meeting of the Board of Directors of the Company on 2 February 2015, to consider and approve the unaudited financial results of the Company for the quarter ended 31 December 2014Powered by Capital Market - Live NewsBusiness Standard, 1 week ago
Increasingly, making cars go faster falls under the purview of high-performance computing. This is especially true in the case of supersonic cars, vehicles capable of traveling faster than the speed of sound. With its undeniable cool factor and a ...HPC Wire, 1 day ago
9-Dec-2014 Asia | Finance To create India's largest and the world's fifth biggest drugmaker is no mean task, but Sun Pharma and Ranbaxy have received the necessary approval from India's fair trade watchdog, the Competition Commission of India ...Manufacturing Chemist, 1 month ago CCI clears Sun-Ranbaxy merger on condition of selling 7 brands PharmaBiz, 1 month ago Pharma deal cleared with riders Calcutta Telegraph, 1 month ago
on your WebpageAdd Widget >Get your members hooked!